The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy
Abstract
Background In patients with heart failure due to dilated cardiomyopathy, cardiac energy metabolism is impaired, as indicated by a reduction of the myocardial phosphocreatine-to-ATP ratio, measured noninvasively by 31 P-MR spectroscopy. The purpose of this study was to test whether the phosphocreatine-to-ATP ratio also offers prognostic information in terms of mortality prediction as well as how this index compares with well-known mortality predictors such as left ventricular ejection fraction (LVEF) or New York Heart Association (NYHA) class. Methods and Results Thirty-nine patients with dilated cardiomyopathy were followed up for 928±85 days (2.5 years). At study entry, LVEF and NYHA class were determined, and the cardiac phosphocreatine-to-ATP ratio was measured by localized 31 P-MR spectroscopy of the anterior myocardium. During the study period, total mortality was 26%. Patients were divided into two groups, one with a normal phosphocreatine-to-ATP ratio (>1.60; mean±SE, 1.98±0.07; n=19; healthy volunteers: 1.94±0.11, n=30) and one with a reduced phosphocreatine-to-ATP ratio (<1.60; 1.30±0.05; n=20). At reevaluation (mean, 2.5 years), 8 of 20 patients with reduced phosphocreatine-to-ATP ratios had died, all of cardiovascular causes (total and cardiovascular mortality, 40%). Of the 19 patients with normal phosphocreatine-to-ATP ratios, 2 had died (total mortality, 11%), one of cardiovascular causes (cardiovascular mortality, 5%). Kaplan-Meier analysis showed significantly reduced total ( P =.036) and cardiovascular ( P =.016) mortality for patients with normal versus patients with low phosphocreatine-to-ATP ratios. A Cox model for multivariate analysis showed that the phosphocreatine-to-ATP ratio and NYHA class offered significant independent prognostic information on cardiovascular mortality. Conclusions The myocardial phosphocreatine-to-ATP ratio, measured noninvasively with 31 P-MR spectroscopy, is a predictor of both total and cardiovascular mortality in patients with dilated cardiomyopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011
Image-selected in Vivo spectroscopy (ISIS). A new technique for spatially selective nmr spectroscopy
Ordidge, R. J., Connelly, A., & Lohman, J. A. B. (1986) · Journal of Magnetic Resonance (1969) · doi:10.1016/0022-2364(86)90031-4 · Cited by 811
Correlates and prognostic implication of exercise capacity in chronic congestive heart failure
Szlachcic, J., Masse, B. M., Kramer, B. L., Topic, N., & Tubau, J. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90742-8 · Cited by 498
Predictors of total mortality and sudden death in mild to moderate heart failure
Gradman, A., Deedwania, P., Cody, R., Massie, B., Packer, M., Pitt, B., & Goldstein, S. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90093-4 · Cited by 394
Neubauer, S., Krahe, T., Schindler, R., Horn, M., Hillenbrand, H., Entzeroth, C., Mader, H., Kromer, E. P., Riegger, G. A., & Lackner, K. (1992) · Circulation · doi:10.1161/01.cir.86.6.1810 · Cited by 390
Self-citationPrognostic importance of atrial natriuretic peptide in patients with chronic heart failure
Gottlieb, S. S., Kukin, M. L., Ahern, D., & Packer, M. (1989) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(89)90344-6 · Cited by 354
Cited by
The Failing Heart — An Engine Out of Fuel
Neubauer, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmra063052 · Cited by 2,417
Self-citationMyocardial Substrate Metabolism in the Normal and Failing Heart
Stanley, W. C., Recchia, F. A., & Lopaschuk, G. D. (2005) · Physiological Reviews · doi:10.1152/physrev.00006.2004 · Cited by 2,048
Obesity Phenotypes, Diabetes, and Cardiovascular Diseases
Piché, M.-E., Tchernof, A., & Després, J.-P. (2020) · Circulation Research · doi:10.1161/circresaha.120.316101 · Cited by 1,986
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,373
Left Ventricular Hypertrophy: Pathogenesis, Detection, and Prognosis
Lorell, B. H., & Carabello, B. A. (2000) · Circulation · doi:10.1161/01.cir.102.4.470 · Cited by 1,232
Cardiac Metabolism in Heart Failure: Implications Beyond ATP Production
Doenst, T., Nguyen, T. D., & Abel, E. D. (2013) · Circulation Research · doi:10.1161/circresaha.113.300376 · Cited by 1,111
Mitochondrial dysfunction in pathophysiology of heart failure
Zhou, B., & Tian, R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120849 · Cited by 923
WRITING COMMITTEE MEMBERS, Hundley, W. G., Bluemke, D. A., Finn, J. P., Flamm, S. D., Fogel, M. A., Friedrich, M. G., Ho, V. B., Jerosch-Herold, M., Kramer, C. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d44a8f · Cited by 821
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
Kolwicz, S. C., Purohit, S., & Tian, R. (2013) · Circulation Research · doi:10.1161/circresaha.113.302095 · Cited by 813
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report?
PENNELL, D. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.040 · Cited by 747
Tham, Y. K., Bernardo, B. C., Ooi, J. Y. Y., Weeks, K. L., & McMullen, J. R. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1477-x · Cited by 708
The Failing Heart Relies on Ketone Bodies as a Fuel
Aubert, G., Martin, O. J., Horton, J. L., Lai, L., Vega, R. B., Leone, T. C., Koves, T., Gardell, S. J., Krüger, M., Hoppel, C. L., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.017355 · Cited by 707
Metabolic remodelling in heart failure
Bertero, E., & Maack, C. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0044-6 · Cited by 706
Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation
Mihm, M. J., Yu, F., Carnes, C. A., Reiser, P. J., McCarthy, P. M., Van Wagoner, D. R., & Bauer, J. A. (2001) · Circulation · doi:10.1161/01.cir.104.2.174 · Cited by 667
Kenny, H. C., & Abel, E. D. (2019) · Circulation Research · doi:10.1161/circresaha.118.311371 · Cited by 660
Is the Failing Heart Energy Starved?: On Using Chemical Energy to Support Cardiac Function
Ingwall, J. S., & Weiss, R. G. (2004) · Circulation Research · doi:10.1161/01.res.0000137170.41939.d9 · Cited by 604
Self-citationACCF/ACR/AHA/NASCI/SCMR 2010 Expert Consensus Document on Cardiovascular Magnetic Resonance
Hundley, W. G., Bluemke, D. A., Finn, J. P., Flamm, S. D., Fogel, M. A., Friedrich, M. G., Ho, V. B., Jerosch-Herold, M., Kramer, C. M., Manning, W. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.11.011 · Cited by 593
The ABC transporter structure and mechanism: perspectives on recent research
Jones, P. M., & George, A. M. (2004) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3336-9 · Cited by 578
Abnormal Cardiac and Skeletal Muscle Energy Metabolism in Patients With Type 2 Diabetes
Scheuermann-Freestone, M., Madsen, P. L., Manners, D., Blamire, A. M., Buckingham, R. E., Styles, P., Radda, G. K., Neubauer, S., & Clarke, K. (2003) · Circulation · doi:10.1161/01.cir.0000072789.89096.10 · Cited by 525
Self-citationBlair, E. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.11.1215 · Cited by 528
Metabolic Mechanisms in Heart Failure
Ashrafian, H., Frenneaux, M. P., & Opie, L. H. (2007) · Circulation · doi:10.1161/circulationaha.107.702795 · Cited by 521
Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy
Dávila-Román, V. G., Vedala, G., Herrero, P., de las Fuentes, L., Rogers, J. G., Kelly, D. P., & Gropler, R. J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01967-8 · Cited by 513
Energy metabolism in heart failure
Ventura‐Clapier, R., Garnier, A., & Veksler, V. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2003.055095 · Cited by 499
Mitochondrial oxidative stress in aging and healthspan
Dai, D.-F., Chiao, Y. A., Marcinek, D. J., Szeto, H. H., & Rabinovitch, P. S. (2014) · Longevity & Healthspan · doi:10.1186/2046-2395-3-6 · Cited by 484
Energy metabolism in heart failure and remodelling
Ingwall, J. S. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn301 · Cited by 466
Self-citationLoss of Metabolic Flexibility in the Failing Heart
Karwi, Q. G., Uddin, G. M., Ho, K. L., & Lopaschuk, G. D. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00068 · Cited by 442
Animal models of human cardiovascular disease, heart failure and hypertrophy
Hasenfuss, G. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00110-2 · Cited by 441
Crilley, J. G., Boehm, E. A., Blair, E., Rajagopalan, B., Blamire, A. M., Styles, P., McKenna, W. J., Östman-Smith, I., Clarke, K., & Watkins, H. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)03009-7 · Cited by 438
Congestive Heart Failure: Fifty Years of Progress
Braunwald, E., & Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.102.suppl_4.iv-14 · Cited by 437
Johnson, B. D., Shaw, L. J., Buchthal, S. D., Bairey Merz, C. N., Kim, H.-W., Scott, K. N., Doyle, M., Olson, M. B., Pepine, C. J., den Hollander, J., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130642.79868.b2 · Cited by 414
del Monte, F., Williams, E., Lebeche, D., Schmidt, U., Rosenzweig, A., Gwathmey, J. K., Lewandowski, E. D., & Hajjar, R. J. (2001) · Circulation · doi:10.1161/hc3601.095574 · Cited by 382
The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense
Horton, J. L., Davidson, M. T., Kurishima, C., Vega, R. B., Powers, J. C., Matsuura, T. R., Petucci, C., Lewandowski, E. D., Crawford, P. A., Muoio, D. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.124079 · Cited by 364
Heart failure with preserved ejection fraction: from mechanisms to therapies
Lam, C. S. P., Voors, A. A., de Boer, R. A., Solomon, S. D., & van Veldhuisen, D. J. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy301 · Cited by 355
PGC-1 Coactivators in Cardiac Development and Disease
Rowe, G. C., Jiang, A., & Arany, Z. (2010) · Circulation Research · doi:10.1161/circresaha.110.223818 · Cited by 355
ATP flux through creatine kinase in the normal, stressed, and failing human heart
Weiss, R. G., Gerstenblith, G., & Bottomley, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408962102 · Cited by 350
Cardiovascular Magnetic Resonance
Pennell, D. J. (2010) · Circulation · doi:10.1161/circulationaha.108.811547 · Cited by 338
Cardiac Aging: From Molecular Mechanisms to Significance in Human Health and Disease
Dai, D.-F., Chen, T., Johnson, S. C., Szeto, H., & Rabinovitch, P. S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4179 · Cited by 334
“The magnitude of this reduction is related to the severity of heart failure (224) and is shown to predict mortality in patients with dilated cardiomyopathy (229).”
BackgroundUncoupling proteins in human heart
Murray, A. J., Anderson, R. E., Watson, G. C., Radda, G. K., & Clarke, K. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17402-3 · Cited by 296
Heart failure with a normal ejection fraction
Sanderson, J. E. (2007) · Heart · doi:10.1136/hrt.2005.074187 · Cited by 295
Biochemistry of protein tyrosine nitration in cardiovascular pathology
PELUFFO, G., & RADI, R. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.024 · Cited by 291
Lai, L., Leone, T. C., Keller, M. P., Martin, O. J., Broman, A. T., Nigro, J., Kapoor, K., Koves, T. R., Stevens, R., Ilkayeva, O. R., et al. (2014) · Circulation: Heart Failure · doi:10.1161/circheartfailure.114.001469 · Cited by 291
Finck, B. N., & Kelly, D. P. (2007) · Circulation · doi:10.1161/circulationaha.107.670588 · Cited by 282
Clinical Indications for Cardiovascular Magnetic Resonance (CMR): Consensus Panel Report #
Pennell, D., Sechtem, U., Higgins, C., Manning, W., Pohost, G., Rademakers, F., van Rossum, A., Shaw, L., & Kent Yucel, E. (2004) · Journal of Cardiovascular Magnetic Resonance · doi:10.1081/jcmr-200038581 · Cited by 274
Huss, J. M., Imahashi, K.-I., Dufour, C. R., Weinheimer, C. J., Courtois, M., Kovacs, A., Giguère, V., Murphy, E., & Kelly, D. P. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.005 · Cited by 266
Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?
VANBILSEN, M., SMEETS, P., GILDE, A., & VANDERVUSSE, G. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2003.11.014 · Cited by 261
Mitochondria in the diabetic heart
Bugger, H., & Abel, E. D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq239 · Cited by 260
Excitation-contraction coupling and mitochondrial energetics
Maack, C., & O'Rourke, B. (2007) · Basic Research in Cardiology · doi:10.1007/s00395-007-0666-z · Cited by 256
Relationship Between Left Ventricular Structural and Metabolic Remodeling in Type 2 Diabetes
Levelt, E., Mahmod, M., Piechnik, S. K., Ariga, R., Francis, J. M., Rodgers, C. T., Clarke, W. T., Sabharwal, N., Schneider, J. E., Karamitsos, T. D., et al. (2016) · Diabetes · doi:10.2337/db15-0627 · Cited by 254
Self-citationRitterhoff, J., & Tian, R. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00887-x · Cited by 254
Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes
Levelt, E., Pavlides, M., Banerjee, R., Mahmod, M., Kelly, C., Sellwood, J., Ariga, R., Thomas, S., Francis, J., Rodgers, C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.597 · Cited by 222
Self-citationEctopic lipids and organ function.
Szendroedi, J., & Roden, M. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328321b3a8 · Cited by 200
Martin, A. S., Abraham, D. M., Hershberger, K. A., Bhatt, D. P., Mao, L., Cui, H., Liu, J., Liu, X., Muehlbauer, M. J., Grimsrud, P. A., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.93885 · Cited by 128
Balestrino, M., Sarocchi, M., Adriano, E., & Spallarossa, P. (2016) · Amino Acids · doi:10.1007/s00726-016-2173-8 · Cited by 60
Myocardial fatty acid metabolism and cardiac performance in heart failure
Tuunanen, H., Ukkonen, H., & Knuuti, J. (2008) · Current Cardiology Reports · doi:10.1007/s11886-008-0024-2 · Cited by 49
Myocardial Energetics In Cardiac Hypertrophy
Zhang, J. (2002) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2002.03657.x · Cited by 49
Bioenergetics of the aging heart and skeletal muscles: Modern concepts and controversies
Tepp, K., Timohhina, N., Puurand, M., Klepinin, A., Chekulayev, V., Shevchuk, I., & Kaambre, T. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.04.001 · Cited by 21
GRKs and β-Arrestins: “Gatekeepers” of Mitochondrial Function in the Failing Heart
Sorriento, D., Gambardella, J., Fiordelisi, A., Iaccarino, G., & Illario, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00064 · Cited by 16
Weighted averaging in spectroscopic studies improves statistical power
Miller, J. J., Cochlin, L., Clarke, K., & Tyler, D. J. (2017) · Magnetic Resonance in Medicine · doi:10.1002/mrm.26615 · Cited by 16
Metadata
- Authors
- Neubauer, S., Horn, M., Cramer, M., Harre, K., Newell, J. B., Peters, W., Pabst, T., Ertl, G., Hahn, D., Ingwall, J. S., & Kochsiek, K.
- Venue
- Circulation
- Published
- 1997-10-07
- Volume
- 96
- Issue
- 7
- Pages
- 2190-2196
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1997997206
- Cited by
- 745
- References
- 37
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.